August 6, 2018
States that require prescribers to register for prescription drug monitoring programs have seen a reduction in the number of prescriptions issued for Schedule II opioids to Medicaid enrollees by up to 10 percent, according to research from Weill Cornell Medicine investigators.
Drug monitoring programs provide prescribers with an online record of a patient’s history of controlled substance use, and currently operate in every state and the District of Columbia except Missouri. These programs, which track the prescribing and dispensing of controlled prescription drugs, help identify possible misuse.
- Faculty Updates